Aymen Abdalkader Shaibatalhamd Increases Stake in CorMedix Inc. to 5.9%

Aymen Abdalkader Shaibatalhamd, an individual investor based in Riyadh, Saudi Arabia, has filed a Schedule 13G/A (Amendment No. 5) regarding his holdings in CorMedix Inc. (CRMD). As of the event date on June 11, 2026, Shaibatalhamd reported beneficial ownership of 4,618,511 shares of common stock, representing 5.9% of the company's outstanding shares. This filing marks an increase from a previously reported 0.0% position, indicating a significant new accumulation of shares. The investor has sole voting and dispositive power over the entire reported amount. The filing was made under Rule 13d-1(c), certifying that the shares were not acquired for the purpose of changing or influencing the control of the issuer. CorMedix Inc. is a biopharmaceutical company headquartered in Parsippany, New Jersey. The reporting person is a citizen of Saudi Arabia and holds the securities for investment purposes.